Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about disclosure

02 May 2024 Evaluate

With reference to its letter dated February 5, 2024, informing about disposal of business assets of Eugia US Manufacturing LLC, a wholly owned step- down subsidiary of the Company. In this regard, Aurobindo Pharma has informed that the aforementioned disposal of business assets has been completed on May 1, 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..